Moss David J — SEC Form 4 filings
SEC reporting owner CIK 1421930. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-23 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 35,718 shares, $251,885 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: purchase of 18,028 shares @ $8.32 ($149,993) in Inmune Bio, Inc., filed 2024-04-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inmune Bio, Inc. (INMB) | Chief Executive Officer, Director | 9 | 3 legs · 35,718 sh · $251,885 | — | 25 |
Form 4 filings — Moss David J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Inmune Bio, Inc. (INMB) | Option exercise (M): 9,014 @ $1.40 · Option exercise/expiry (X): 9,014 (derivative) @ $0.12 | EDGAR |
| 2025-12-02 | 4 | Inmune Bio, Inc. (INMB) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Inmune Bio, Inc. (INMB) | Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 400,000 (derivative) · Disposition to issuer (D): 59,337 (derivative) · Grant/award (A): 59,337 (derivative) · Disposition to issuer (D): 275,000 (derivative) · Grant/award (A): 275,000 (derivative) · +10 more | EDGAR |
| 2024-12-09 | 4 | Inmune Bio, Inc. (INMB) | Grant/award (A): 223,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Inmune Bio, Inc. (INMB) | Purchase (P): 10,000 @ $5.29 | EDGAR |
| 2024-09-16 | 4 | Inmune Bio, Inc. (INMB) | Purchase (P): 7,690 @ $6.38 · Purchase (P): 7,690 (derivative) @ $0.12 | EDGAR |
| 2024-05-16 | 4 | Inmune Bio, Inc. (INMB) | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4/A | Inmune Bio, Inc. (INMB) | Purchase (P): 18,028 @ $8.32 · Purchase (P): 18,028 (derivative) @ $0.12 | EDGAR |
| 2024-04-23 | 4 | Inmune Bio, Inc. (INMB) | Grant/award (A): 18,028 @ $8.32 · Grant/award (A): 18,028 (derivative) @ $0.12 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1421930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →